| ASBEL | Antisense ncRNA in the ANA/BTG3 locus |
| ASO | Antisense oligonucleotides |
| BARD1 | BRCA1-associated RING domain protein 1 |
| CCAT1 | Colon cancer-associated transcripts 1 |
| CCAT2 | Colon cancer-associated transcripts 2 |
| CHART | Capture hybridization analysis of RNA targets |
| ChIRP | Chromatin isolation by RNA purification |
| CLC | Cancer LncRNA Census |
| EMT | Epithelial to mesenchymal transition |
| ENCODE | Encyclopedia of DNA Elements |
| GAS5 | Growth arrest-specific transcript 5 |
| HOTAIR | HOX antisense intergenic RNA |
| LED | LncRNA activator of enhancer domains |
| lncRNAs | Long ncRNAs |
| lncRNA-ATB | LncRNA-activated by TGF-β |
| ncRNAs | Noncoding RNAs |
| NORAD | Noncoding RNA activated by DNA damage |
| MALAT1 | Metastasis associated in lung adenocarcinoma transcript |
| MINCR | MYC-induced long non-coding RNA |
| NEAT1 | Nuclear enriched abundant transcript 1 |
| PANDA | P21 associated ncRNA DNA damage activated |
| PCAWG | Pan-Cancer Analysis of Whole Genomes |
| PCA3 | Prostate cancer antigen 3 |
| PCAT1 | Prostate cancer associated transcript 1 |
| PCGEM1 | Prostate-specific transcript 1 |
| PTENP1 | PTEN pseudogene |
| PVT1 | Plasmacytoma variant translocation 1 |
| Pol II | RNA polymerase II |
| RAP | RNA antisense purification |
| RIP | RNA immunoprecipitation |
| RNAi | RNA interference |
| RNP | Ribonucleoprotein |
| rRNAs | Ribosomal RNAs |
| SAMMSON | Survival associated mitochondrial melanoma specific oncogenic non-coding RNA |
| SChLAP1 | Second chromosome locus associated with prostate-1 |
| snRNAs | Small nuclear RNAs |
| snoRNAs | Small nucleolar RNAs |
| TARID | TCF21 antisense RNA inducing demethylation |
| TCGA | The Cancer Genome Atlas |
| Terra | Telomeric repeat-containing RNA |
| TINCR | Terminal differentiation-induced noncoding RNA |
| tRNAs | Transfer RNAs |
| UPAT | UHRF1 protein associated transcript |
| ZFNs | Zinc finger nucleases |